FDA Approved: VIMPAT — Original Application (UCB, Inc.)

View source ↗

Summary

FDA approved VIMPAT (lacosamide) through its original NDA for adjunctive treatment of partial-onset seizures in adults and in pediatric patients aged 4 years an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Vimpat (lacosamide)

Snippet

ORIG AP for VIMPAT (LACOSAMIDE)